Corient Private Wealth
COCH icon

Corient Private Wealth’s Envoy Medical COCH Stock Holding History

Corient Private Wealth’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-76,324
Closed -$50.5K – 2874
2025
Q4 		$50.5K Buy
76,324
+38,162
+100% +$30.2K ﹤0.01% 2673
2025
Q3 		$29.6K Hold
38,162
– – ﹤0.01% 2517
2025
Q2 		$54.2K Hold
38,162
– – ﹤0.01% 2378
2025
Q1 		$49.6K Hold
38,162
– – ﹤0.01% 2225
2024
Q4 		$54.6K Hold
38,162
– – ﹤0.01% 2274
2024
Q3 		$124K Hold
38,162
– – ﹤0.01% 2298
2024
Q2 		$90.1K Buy
+38,162
New +$142K ﹤0.01% 2225

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Corient Private Wealth's COCH Position: Q1 2026 in Review

Corient Private Wealth sold out of Envoy Medical (COCH) in Q1 2026, closing a stake of 76,324 shares — an estimated $50.5K sold.

Corient Private Wealth first reported a position in COCH in Q2 2024 and held it in 7 quarters. The position peaked at $124K in Q3 2024. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Corient Private Wealth reported no remaining Envoy Medical position as of Q1 2026 after selling out during the quarter.
  • Corient Private Wealth sold 76,324 Envoy Medical shares in Q1 2026, an estimated $50.5K.
  • Corient Private Wealth first reported a position in Envoy Medical in Q2 2024 and held it in 7 quarters.
  • Corient Private Wealth's Envoy Medical position peaked at $124K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.